Intel's decision to sell a 20% stake in its IMS Nanofabrication business to Bain Capital may not have a significant short-term impact on its stock price. The sale values IMS at approximately $4.3 billion, which is a relatively small portion of Intel's overall market capitalization. However, the deal could potentially free up resources for Intel to focus on its core business and improve its financial position.